ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · IEX Real-Time Price · USD
0.211
-0.009 (-3.95%)
Jul 19, 2024, 4:00 PM EDT - Market closed
ReShape Lifesciences Market Cap
ReShape Lifesciences has a market cap or net worth of $6.21 million as of July 22, 2024. Its market cap has increased by 47.91% in one year.
Market Cap
6.21M
Enterprise Value
3.97M
1-Year Change
47.91%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since October 6, 2016, ReShape Lifesciences's market cap has decreased from $239.30M to $6.21M, a decrease of -97.40%. That is a compound annual growth rate of -37.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.90M | 48.48% |
| Dec 29, 2023 | 3.30M | - |
| Dec 30, 2022 | 3.30M | -88.70% |
| Dec 31, 2021 | 29.20M | 149.57% |
| Dec 31, 2020 | 11.70M | -19.86% |
| Dec 31, 2019 | 14.60M | -69.71% |
| Dec 31, 2018 | 48.20M | -58.20% |
| Dec 29, 2017 | 115.30M | -22.30% |
| Dec 30, 2016 | 148.40M | -37.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 6.70M |
| NuCana | 6.69M |
| Telesis Bio | 6.69M |
| Xenetic Biosciences | 6.41M |
| Chromocell Therapeutics | 6.40M |
| Pasithea Therapeutics | 6.10M |
| CareMax | 6.01M |
| SunLink Health Systems | 6.00M |